1620 Investment Advisors’s Bio-Techne TECH Stock Holding History

1620 Investment Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$651	–	749
2024 Q3	$651	Buy	+8	New	+$601	﹤0.01%	664

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

1620 Investment Advisors's TECH Position: Q4 2024 in Review

1620 Investment Advisors sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 8 shares — an estimated $651 sold.

1620 Investment Advisors first reported a position in TECH in Q3 2024 and held it in 1 quarter. The position peaked at $651 in Q3 2024. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

1620 Investment Advisors reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
1620 Investment Advisors sold 8 Bio-Techne shares in Q4 2024, an estimated $651.
1620 Investment Advisors first reported a position in Bio-Techne in Q3 2024 and held it in 1 quarter.
1620 Investment Advisors's Bio-Techne position peaked at $651 in Q3 2024.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on 1620 Investment Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.